Compounds > austin
Page last updated: 2024-11-13

austin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

austin: toxic metabolite of Aspergillus ustus found on stored black-eyed peas [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID38353601
MeSH IDM0060016

Synonyms (11)

Synonym
unii-ttt25xe98e
nsc 280416
ttt25xe98e ,
austin
nsc-280416
61103-89-7
spiro(3ah-6,11b-methano-3h-benzo(e)furo(3,4-c)oxocin-9(10h),3'(6'h)-(2h)pyran)-1,4,6'-trione, 7-(acetyloxy)-6,7,11,11a-tetrahydro-3a-hydroxy-2',2',3,6,8,11a-hexamethyl-12-methylene-, (3s,3's,3as,6r,7r,11ar,11bs)-
(3s-(3.alpha.,3a.alpha.,6.beta.,7.beta.,9.beta.,11a.beta.,11b.beta.))-7-(acetyloxy)-3,3a,6,7,11,11a-hexahydro-3a-hydroxy-2',2',3,6,8,11a-hexamethyl-12-methylenespiro(1h-6,11b-methano-4h-furo(3,4-e)(3)benzoxocin-9(10h),3'(6'h)-(2h)pyran)-1,4,6'-trione
spiro(1h-6,11b-methano-4h-furo(3,4-e)(3)benzoxocin-9(10h),3'(6'h)-(2h)pyran)-1,4,6'-trione, 7-(acetyloxy)-3,3a,6,7,11,11a-hexahydro-3a-hydroxy-2',2',3,6,8,11a-hexamethyl-12-methylene-, (3s,3's,3as,6r,7r,11ar,11bs)-
Q27290349
DTXSID00893994
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (7 Items)

ItemProcessFrequency
es:Mctcore-ingredient1
Plant-based milk alternativescore-ingredient1
Plant-based beveragescore-ingredient1
Milk substitutescore-ingredient1
Dairy substitutescore-ingredient1
Beveragescore-ingredient1
Plant-based foods and beveragescore-ingredient1

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (69.23)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (23.08)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 124.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index124.30 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index224.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (124.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
isocoumarins
Isocoumarins: Compounds that differ from COUMARINS in having the positions of the ring and ketone oxygens reversed so the keto oxygen is at the 1-position of the molecule.. isocoumarin : The simplest member of the class of isocoumarins that is 1H-isochromene which is substituted by an oxo group at position 1.		2.1510isocoumarins
ConditionIndicatedRelationship StrengthStudiesTrials
Cardiac Murmurs
[description not available]		02.8540
Mitral Stenosis
[description not available]		02.3420
Mitral Valve Stenosis
Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.		02.3420
Intertrochanteric Fractures
[description not available]		01.9310
Hip Fractures
Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).		01.9310
Arthropathies
[description not available]		01.9310
Joint Diseases
Diseases involving the JOINTS.		01.9310
Hospital-Acquired Condition
[description not available]		01.9410
Femur Neck Fractures
[description not available]		01.9410
Peripheral Nerve Diseases
[description not available]		01.9410
Complication, Postoperative
[description not available]		01.9410
Femoral Neck Fractures
Fractures of the short, constricted portion of the thigh bone between the femur head and the trochanters. It excludes intertrochanteric fractures which are HIP FRACTURES.		01.9410
Peripheral Nervous System Diseases
Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.		01.9410
Postoperative Complications
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.		01.9410
Aortic Incompetence
[description not available]		01.9410
Aortic Diseases
Pathological processes involving any part of the AORTA.		01.9410
Aortic Valve Insufficiency
Pathological condition characterized by the backflow of blood from the ASCENDING AORTA back into the LEFT VENTRICLE, leading to regurgitation. It is caused by diseases of the AORTIC VALVE or its surrounding tissue (aortic root).		01.9410
Bouillaud Disease
[description not available]		01.9310
Rheumatic Heart Disease
Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.		01.9310